CORT

Corcept Therapeutics Incorporated is a biopharmaceutical company based in Menlo Park, California, focused on developing innovative therapies that modulate cortisol to treat severe metabolic, psychiatric, and oncological conditions. The company's proprietary approach aims to address significant unmet medical needs, leveraging a promising pipeline of product candidates that are designed to enhance patient outcomes significantly. As Corcept advances its clinical programs, it stands positioned to deliver value not only to patients but also to its shareholders by addressing critical gaps in current treatment paradigms.